HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,695,677 | +283.6% | 29,801 | +196.5% | 0.01% | +350.0% |
Q2 2022 | $442,000 | -36.4% | 10,050 | -39.8% | 0.00% | 0.0% |
Q1 2021 | $695,000 | -76.9% | 16,682 | -76.3% | 0.00% | -75.0% |
Q4 2020 | $3,006,000 | +138.6% | 70,372 | +46.8% | 0.01% | +100.0% |
Q3 2020 | $1,260,000 | -21.7% | 47,931 | -20.1% | 0.00% | -20.0% |
Q2 2020 | $1,609,000 | -22.9% | 60,000 | -48.3% | 0.01% | 0.0% |
Q1 2020 | $2,086,000 | +78.3% | 116,000 | +75.8% | 0.01% | +25.0% |
Q4 2019 | $1,170,000 | +14.3% | 66,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $1,024,000 | -0.7% | 66,000 | +10.0% | 0.00% | 0.0% |
Q2 2019 | $1,031,000 | -72.8% | 60,000 | -74.5% | 0.00% | -73.3% |
Q1 2019 | $3,785,000 | +4.6% | 235,121 | -5.0% | 0.02% | -11.8% |
Q4 2018 | $3,620,000 | -28.8% | 247,420 | -11.6% | 0.02% | -10.5% |
Q3 2018 | $5,083,000 | -15.3% | 279,761 | -21.3% | 0.02% | -24.0% |
Q2 2018 | $5,999,000 | -24.5% | 355,582 | -12.4% | 0.02% | -32.4% |
Q1 2018 | $7,950,000 | -2.1% | 405,819 | +1.3% | 0.04% | 0.0% |
Q4 2017 | $8,119,000 | +27.9% | 400,722 | +9.7% | 0.04% | +23.3% |
Q3 2017 | $6,347,000 | +49.4% | 365,394 | +10.3% | 0.03% | +50.0% |
Q2 2017 | $4,248,000 | -10.0% | 331,394 | -9.0% | 0.02% | -13.0% |
Q1 2017 | $4,718,000 | +29.6% | 364,014 | -1.2% | 0.02% | +15.0% |
Q4 2016 | $3,641,000 | -16.0% | 368,566 | +2.7% | 0.02% | -9.1% |
Q3 2016 | $4,337,000 | +16.2% | 359,009 | -17.0% | 0.02% | +10.0% |
Q2 2016 | $3,731,000 | -5.0% | 432,289 | +4.2% | 0.02% | 0.0% |
Q1 2016 | $3,927,000 | -53.8% | 414,706 | -15.4% | 0.02% | -51.2% |
Q4 2015 | $8,493,000 | +21.0% | 490,084 | -6.2% | 0.04% | +7.9% |
Q3 2015 | $7,018,000 | +7.7% | 522,527 | +81.1% | 0.04% | +31.0% |
Q2 2015 | $6,515,000 | – | 288,526 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |